This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Shanghai Escugen Biotechnology Co., Ltd., Shanghai Escugen Biotechnology Co., Ltd.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2025-2026
Title: Xintong Zheng: Innovator in Antibody Development
Introduction
Xintong Zheng is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His innovative work has led to the creation of a unique single-domain antibody targeting human CD47.
Latest Patents
Xintong Zheng holds a patent for a "Human CD47-targeting single-domain antibody and use thereof." This patent relates to an anti-CD47 single-domain antibody and its applications, as well as a method for preparing the antibody. The single-domain antibody comprises a CDR selected from specific sequences, showcasing his expertise in antibody engineering. He has 1 patent to his name.
Career Highlights
Zheng is currently associated with Shanghai Escugen Biotechnology Co., Ltd., where he continues to advance his research and development efforts. His work is pivotal in the ongoing exploration of therapeutic applications for antibodies in treating various diseases.
Collaborations
Xintong Zheng collaborates with talented professionals in his field, including Xiangyu He and Weihong Nian, who contribute to the innovative environment at Shanghai Escugen Biotechnology Co., Ltd.
Conclusion
Xintong Zheng's contributions to antibody development highlight his role as an influential inventor in the biotechnology sector. His innovative patent work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile